Drawing for TEVA

USPTO serial 88667786

TEVA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
WATSON, BRIDGET ANNE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TEVA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laurence Rickles

LAURENCE RICKLES TEVA PHARMACEUTICALS USA, INC.400 INTERPACE PARKWAYTRADEMARKS DEPARTMENTPARSIPPANY, NJ 07054

Goods and services

ClassDescriptionStatusFirst use
005Human pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, depression, psychological disorders, diabetes and diabetic neuropathy, cardiovascular and blood pressure disorders, irritable bowel syndrome, neurodegenerative diseases and disorders, osteoporosis, pain and neuropathic pain, peripheral nervous system diseases and disorders, digestive tract disorders, gastrointestinal and dermatological diseases and disorders, respiratory system diseases and disorders, sexual dysfunction, symptoms associated with uterine fibroids, urinary incontinence and overactive bladder, AIDS-related disorders, cancer, central nervous system diseases, circulatory system diseases, sensory organ diseases, urogenital organ diseases, peripheral nervous system diseases, bone disorders and bone diseases; Human pharmaceutical preparations, namely, injectable contraceptives, contraceptive preparations, fertility enhancement preparations, and hormone replacement therapy preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 14, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 14, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 27, 2020DOCKASSIGNED TO EXAMINER—
May 12, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 17, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 17, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 26, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 10, 2020ALIEASSIGNED TO LIE—
Jan 30, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 29, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jan 29, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 29, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 29, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 23, 2020DOCKASSIGNED TO EXAMINER—
Oct 31, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 30, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 28, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance